Found: 13
Select item for more details and to access through your institution.
Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 693, doi. 10.1007/s00280-020-04158-1
- By:
- Publication type:
- Article
Comparative efficacy and safety of trastuzumab biosimilars to the reference drug: a systematic review and meta-analysis of randomized clinical trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 577, doi. 10.1007/s00280-020-04156-3
- By:
- Publication type:
- Article
Efficacy and safety of oral magnesium supplementation in reducing febrile neutropenia episodes in children with solid tumors treated with cisplatin-based chemotherapy: randomized clinical trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 673, doi. 10.1007/s00280-020-04155-4
- By:
- Publication type:
- Article
In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 633, doi. 10.1007/s00280-020-04154-5
- By:
- Publication type:
- Article
Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 663, doi. 10.1007/s00280-020-04152-7
- By:
- Publication type:
- Article
Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 687, doi. 10.1007/s00280-020-04150-9
- By:
- Publication type:
- Article
Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Physiologically based pharmacokinetic modeling and simulation to predict drug–drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 619, doi. 10.1007/s00280-020-04148-3
- By:
- Publication type:
- Article
A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 589, doi. 10.1007/s00280-020-04146-5
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of phase 1 bemarituzumab data to support phase 2 gastroesophageal adenocarcinoma FIGHT trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 595, doi. 10.1007/s00280-020-04139-4
- By:
- Publication type:
- Article
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 607, doi. 10.1007/s00280-020-04135-8
- By:
- Publication type:
- Article